Related Experiment Video
Updated: May 12, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
Published on: December 30, 2025
MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression
Xinyu Wu1, Daixing Zhong, Quan Gao
1Department of Neurology, the Affiliated Southeast Hospital of Xiamen University, Zhangzhou 363000, China.
Abstract:
Aberrant expression of MicroRNAs (miRNAs) has been implicated in several types of cancer. As a direct target gene of p53, miR-34a has been suggested to mediate the tumor suppressor function of p53. Ether à go-go 1 (Eag1) channel is overexpressed in a variety of cancers and plays important roles in cancer progression. However, the link between miR-34a and Eag1 in cancer is unclear. In this study, we used human osteosarcoma as the model to demonstrate that miR-34a was significantly downregulated in osteosarcoma tissues and cell lines compared with normal brain tissues and osteoblastic cell line. Next we evaluated the role of miR-34a in the regulation of osteosarcoma cell proliferation by CCK-8 and colony formation assays. The results showed that overexpression of miR-34a inhibited the proliferation of MG-63 and Saos-2 cells. Furthermore, xenograft nude mice model showed that miR-34a inhibited osteosarcoma growth in vivo. Mechanistically, we found that overexpression of miR-34a led to decreased Eag1 expression in osteosarcoma cells while inhibition of miR-34a increased Eag1 expression. Taken together, our results suggest that miR-34a could inhibit osteosarcoma growth via the down regulation of Eag1 expression.
Insights
MicroRNA 34a (miR-34a) is downregulated in osteosarcoma, inhibiting cancer growth by reducing Ether à go-go 1 (Eag1) channel expression. This study reveals miR-34a as a potential therapeutic target for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Aberrant microRNA (miRNA) expression is linked to various cancers.
- miR-34a, a p53 target, is implicated in tumor suppression.
- Ether à go-go 1 (Eag1) channel overexpression promotes cancer progression.
Purpose of the Study:
- Investigate the relationship between miR-34a and Eag1 in osteosarcoma.
- Determine the role of miR-34a in regulating osteosarcoma cell proliferation.
- Elucidate the mechanism by which miR-34a affects osteosarcoma growth.
Main Methods:
- Analysis of miR-34a expression in osteosarcoma tissues and cell lines.
- Cell proliferation assays (CCK-8, colony formation) with miR-34a overexpression.
- In vivo studies using a xenograft nude mice model.
- Assessment of Eag1 expression following miR-34a manipulation.
Main Results:
- miR-34a was significantly downregulated in osteosarcoma.
- Overexpression of miR-34a inhibited osteosarcoma cell proliferation in vitro.
- miR-34a suppressed osteosarcoma tumor growth in vivo.
- miR-34a directly downregulates Eag1 expression in osteosarcoma cells.
Conclusions:
- miR-34a acts as a tumor suppressor in osteosarcoma.
- The tumor-suppressive function of miR-34a is mediated through the downregulation of Eag1.
- miR-34a represents a potential therapeutic target for osteosarcoma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
